Skip to main content
Clinical Trials/NCT02878005
NCT02878005
Unknown
Not Applicable

A Prospective and Randomized Study Comparing the New Intubating Laryngeal Tube Suction and the Ambu AuraGain in Adult Patients

Bnai Zion Medical Center0 sites60 target enrollmentAugust 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intubation; Difficult
Sponsor
Bnai Zion Medical Center
Enrollment
60
Primary Endpoint
Time to performe blind intubation measure in second
Last Updated
9 years ago

Overview

Brief Summary

The intubating Laryngeal Tube Suction-Disposable is a new version of the Laryngeal Tube-Suction. It has a ventilator channel with a 13.5mm internal diameter, which enables the passage of an Endotracheal Tube either blindly or with fiberoptic guidance.This study was designed to assess the success rate of blind and fiberoptic endotracheal intubation using iLTS-D, in comparison with the and Ambu® AuraGain™ in adult patients.

Detailed Description

The intubating Laryngeal Tube Suction-Disposable (iLTS-D) (VBM Medizintechnik GmbH, Sulz, Germany) is a new updated version of the Laryngeal Tube-Suction Disposable (LTS-D) It has a ventilator channel with a 13.5mm internal diameter, which enables the passage of an Endotracheal Tube (ETT) either blindly or with fiberoptic guidance. Similarly As in to the LTS-D, the iLTS-D also has a separate channel for the purpose of placement of gastric tubes placement up to a size of 18 Fr. The iLTS-D comes in one size. According to the depth of insertion, this device is equivalent to size 4 for patients 175patients 175 to 190 cm tall, or size 5 for patients taller than 190 cm. The iLTS-D is provided by the manufacturer with a compatible 7.5mm ETT and with a plastic stabilizer for removal of the device. The current randomized study was designed to assess the success rate of blind and fiberoptic endotracheal intubation using iLTS-D, in comparison with the and Ambu® AuraGain™ in adult patients under general anesthesia

Registry
clinicaltrials.gov
Start Date
August 2016
End Date
July 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

LUIS.GAITINI

M.D.

Bnai Zion Medical Center

Eligibility Criteria

Inclusion Criteria

  • American Society Anesthesiology I and II

Exclusion Criteria

  • Difficult intubation, Cervical pathology

Outcomes

Primary Outcomes

Time to performe blind intubation measure in second

Time Frame: 30 seconds

Secondary Outcomes

  • Time to performe fiberoptic intubation in second(60 seconds)

Similar Trials